Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Qual Life Res ; 14(2): 493-500, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15892438

ABSTRACT

PURPOSE: To determine the effect on patient responses from the order in which the generic health-related and vision-targeted instruments are administered in a set of randomized clinical trials of intraocular surgery. PATIENTS AND METHODS: Patients who agreed to enroll in the Submacular Surgery Trials (SST) completed baseline quality of life interviews prior to random assignment to surgery or observation. Interviews were conducted by trained interviewers located at the SST Coordinating Center, via a computer-assisted telephone interview system that randomly assigned the order of instrument administration. Either the generic health-related instruments were administered first, the SF-36 Health Survey (SF-36) followed by the Hospital Anxiety and Depression Scale (HADS), followed by the vision-targeted instruments, National Eye Institute-Vision Function Questionnaire (NEI-VFQ) followed by the SST-Vision Preference Value Scale, or the vision-targeted questions were asked first, followed by the generic health instruments. The four instruments have 25 subscales total. RESULTS: Of the 1015 patients enrolled in the SST, 992 patients had all four instruments administered in random order: 483 (49%) patients responded to the generic instruments first and 509 (51%) patients responded to the vision-targeted instruments first. Order of administration produced significantly different scores for three health status subscales: SF-36 mental health, HADS depression and HADS anxiety (p < or = 0.05, Wilcoxon rank sum test). CONCLUSIONS: Overall, the order of administration did not have a large effect on responses to the baseline interviews in this study. However, three mental health subscales were affected by order, though the order effect was small in magnitude. When the generic health instruments followed the vision-targeted instrument the HADS depression and anxiety scores were higher and the SF-36 mental health scores were lower, both suggesting poorer mental health status. Thus, the order of administration in other settings in which both a generic health-related instrument and a condition-targeted instrument are used may be decided based on individual study goals and priorities but order of administration should be consistent throughout the study.


Subject(s)
Choroidal Neovascularization/surgery , Interviews as Topic , Quality of Life , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , United States
2.
Arch Ophthalmol ; 122(12): 1856-67, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15596591

ABSTRACT

OBJECTIVE: To improve understanding and awareness of the impact of subfoveal choroidal neovascularization (CNV) on health-related quality of life, we sought to measure the preference value that patients with subfoveal CNV assigned to their health and vision status. PATIENTS AND METHODS: Patients with subfoveal CNV completed telephone interviews about their quality of life prior to enrollment and random treatment assignment in the Submacular Surgery Trials, a set of multicenter randomized controlled trials evaluating outcomes of submacular surgery compared with observation. The interviewers asked patients to rate their current vision on a scale from 0 (completely blind) to 100 (perfect vision). The interviewers also asked them to rate complete blindness and then perfect vision, assuming their health otherwise was the same as it was at the time of the interview, on a scale from 0 (dead) to 100 (perfect health with perfect vision). Scores were converted to a 0 to 1 preference value scale for health and vision status, where 0 represents death and 1 represents perfect health and vision. RESULTS: Of 1015 participants enrolled in the Submacular Surgery Trials, 996 completed interviews that included the rating questions, and 792 (80%) answered all 3 rating questions in a manner permitting calculation of a single overall preference value for their current health and vision status on a scale from 0 (dead) to 1 (perfect). The mean preference value was 0.64 (median, 0.68; interquartile range, 0.51-0.80). The preference values correlated with age (Pearson correlation coefficient, -0.11; P = .002), patients' self-rated perception of overall health (Spearman correlation coefficient, 0.36; P<.001), and self-reported perception of vision (Spearman correlation coefficient, 0.47; P<.001). The preference values were significantly lower with poorer visual acuity in the better eye and greater evidence of dysfunction on either the Hospital Anxiety and Depression Scale or the Physical or Mental Component Summary scales of the Short Form-36 Health Survey but did not differ significantly by gender or other baseline characteristics such as race, treatment assignment, or size of the CNV lesion. CONCLUSIONS: Vision loss from subfoveal CNV is associated with patient preference values that are as low as or lower than values previously reported for other serious medical conditions such as dialysis-dependent renal failure and AIDS, indicating that both unilateral and bilateral CNV have a profound impact on how patients feel about their overall health-related quality of life.


Subject(s)
Attitude to Health , Choroidal Neovascularization/psychology , Patient Satisfaction , Patients/psychology , Quality of Life/psychology , Vision, Ocular/physiology , Adult , Aged , Aged, 80 and over , Blindness/psychology , Choroidal Neovascularization/surgery , Cross-Sectional Studies , Female , Fovea Centralis , Health Status , Humans , Male , Middle Aged , Surveys and Questionnaires
3.
Arch Ophthalmol ; 122(11): 1616-28, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15534122

ABSTRACT

OBJECTIVE: To report findings regarding health-related quality-of-life outcomes by treatment arm, both overall and within subgroups defined by selected baseline characteristics, among patients who participated in the Submacular Surgery Trials (SST) randomized trial of observation vs surgical removal of subfoveal choroidal neovascular lesions that were either idiopathic or associated with ocular histoplasmosis (SST Group H Trial). DESIGN AND METHODS: Eligible patients were 18 years or older and had subfoveal choroidal neovascularization (including a classic component on fluorescein angiography) and visual acuity of 20/50 to 20/800 inclusive in the eye randomly assigned to surgery or observation. Trained interviewers, who were masked to treatment assignment, administered the National Eye Institute Visual Function Questionnaire (NEI-VFQ), the 36-Item Short-Form Health Survey (SF-36), and the Hospital Anxiety and Depression Scale (HADS) by telephone before enrollment and at 6, 12, and 24 months after enrollment; early enrollees also had interviews at 36 and 48 months. Baseline clinical examinations provided data regarding visual acuity, other aspects of vision, and presence of unilateral or bilateral choroidal neovascularization. RESULTS: Of 225 patients interviewed at baseline and enrolled, 201, 190, and 161 patients (respectively, 89%, 85%, and 88% of those eligible to be interviewed) were interviewed 12, 24, and 36 months later. The NEI-VFQ scores in both treatment arms improved from baseline (median score, 75) to the 24-month interview. Patients in the surgery arm had 4-point larger improvements, on average, than patients in the observation arm (95% confidence interval, 1-8 points). The largest differences between treatment arms for mean 24-month improvements from baseline were in the role difficulties subscale (9 points) and dependency subscale (8 points), with larger mean improvements in the surgery arm. Scores on the SF-36 worsened by approximately 1 point on the physical component summary and improved by 2 points or more on the mental component summary in both treatment arms by 24 months in comparison to baseline. The percentage of HADS-defined "definite cases" of both anxiety and depression declined from baseline in each treatment arm. CONCLUSIONS: Vision-targeted quality of life improved more after submacular surgery than with observation, supporting a possible small overall benefit of surgery suggested by the ophthalmic outcomes reported elsewhere. Ophthalmologists and patients similar to those who participated in the SST Group H Trial should be aware of the effects of submacular surgery on specific aspects of vision-targeted quality of life as well as on ophthalmic outcomes when considering this treatment approach.


Subject(s)
Choroidal Neovascularization/surgery , Eye Infections, Fungal/surgery , Fovea Centralis/surgery , Histoplasmosis/surgery , Quality of Life , Adult , Aged , Choroidal Neovascularization/etiology , Eye Infections, Fungal/complications , Female , Fluorescein Angiography , Fovea Centralis/pathology , Health Status , Histoplasmosis/complications , Humans , Male , Middle Aged , Observation , Ophthalmologic Surgical Procedures , Prospective Studies , Surveys and Questionnaires , Syndrome , Visual Acuity
4.
Ophthalmology ; 111(11): 1981-92, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15522363

ABSTRACT

PURPOSE: To describe health-related quality of life (HRQOL), overall and in patients with unilateral or bilateral choroidal neovascularization (CNV), in a clinical trial (Group N Trial) comparing observation and surgical removal of subfoveal CNV secondary to age-related macular degeneration (AMD). DESIGN: Randomized clinical trial. PARTICIPANTS: Eligible patients had untreated subfoveal CNV and AMD, best-corrected visual acuity (VA) of 20/100 to 20/800, classic CNV on fluorescein angiography, and a total subfoveal lesion size of < or =9.0 disc areas in the study eye. METHODS: Health-related quality of life data (the National Eye Institute Visual Function Questionnaire [NEI-VFQ], 36-item Short Form Health Survey [SF-36], and Hospital Anxiety and Depression Scale [HADS]) and clinical data were collected at baseline and at 6, 12, 24, 36, and 48 months. Patients were divided into unilateral and bilateral CNV subgroups based on fluorescein angiographic and clinical evidence. MAIN OUTCOME MEASURE: Two-year change in the NEI-VFQ. RESULTS: Of 454 patients enrolled, 228 were assigned to observation and 226 to surgery. At baseline, median overall NEI-VFQ scores were 67 in the observation group and 69 in the surgery group; by 2 years, the observation group had lost a median of 3 points (95% confidence interval [CI]: -6 to -2), and the surgery group gained a median of 1 point (CI: -1 to 3). The largest difference was observed for the mental health subscale, where the observation group lost a median of 5 points (CI: -5 to 0), and the surgery group gained a median of 5 points (CI: 0-10) by 2 years. Treatment differences in median 2-year changes in NEI-VFQ scores favored surgery by up to 10 points for unilateral cases and up to 8 points for bilateral cases. No treatment difference in 2-year change was observed for the SF-36 physical component summary; 2-year change in the mental component summary favored surgery by 2 points. Few patients (2%-4%) had HADS definite anxiety or depression at baseline or at 24 months. CONCLUSIONS: Although HRQOL outcomes were better in the submacular surgery arm than in the observation arm, surgery (per protocol) is not recommended because VA outcomes (reported elsewhere) were similar in the treatment arms. This article contains additional online-only material available at http://www.ophsource.com/periodicals/ophtha.


Subject(s)
Choroidal Neovascularization/psychology , Choroidal Neovascularization/surgery , Fovea Centralis/surgery , Macular Degeneration/psychology , Macular Degeneration/surgery , Quality of Life , Aged , Aged, 80 and over , Female , Fluorescein Angiography , Health Status , Humans , Male , Middle Aged , National Institutes of Health (U.S.) , Sensitivity and Specificity , Surveys and Questionnaires , United States , Visual Acuity/physiology
5.
Ophthalmology ; 111(11): 1993-2006, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15522364

ABSTRACT

PURPOSE: To present best-corrected visual acuity (BCVA) findings and other clinical outcomes from eyes of patients enrolled in one of the Submacular Surgery Trials (SST) evaluating surgical removal versus observation of predominantly hemorrhagic subfoveal choroidal neovascularization (CNV) associated with age-related macular degeneration. DESIGN: Randomized clinical trial (SST Group B Trial). PARTICIPANTS: Eligible patients had subfoveal choroidal neovascular lesions greater than 3.5 disk areas (8.9 mm2) composed of at least 50% blood (either blood or CNV underlying the center of the foveal avascular zone) and BCVA of 20/100 to light perception in the study eye. INTERVENTION: Patients were assigned randomly at time of enrollment to observation or surgical removal of blood and any associated CNV. MAIN OUTCOME MEASURE: A successful outcome was defined a priori as either improvement in visual acuity (VA), no change in VA, or a decline in VA of no more than 1 line (7 letters) from baseline to the 24-month examination based on an intent-to-treat analysis. RESULTS: Of 336 patients enrolled, 168 were assigned to each treatment arm; treatment arms were balanced by baseline characteristics. Of 1501 expected examinations 3 months through 36 months after baseline, 1370 (91%) were performed. Loss of > or =2 lines (> or =8 letters) of VA occurred in 56% of surgery eyes, versus 59% of observation eyes examined at 24 months. Although severe loss of VA was not the primary outcome of interest, surgery more often prevented such loss: 36% in the observation arm versus 21% in the surgery arm at the 24-month examination (chi2 P = 0.004). Of initially phakic eyes, the cumulative percentage that had undergone cataract surgery by 24 months was 44% in the surgery arm, compared with 6% in the observation arm. Twenty-seven eyes (16%) in the surgical arm, compared with 3 eyes (2%) in the observation arm, had a rhegmatogenous retinal detachment (RD). CONCLUSIONS: Submacular surgery as performed in the SST Group B Trial did not increase the chance of stable or improved VA (the primary outcome of interest) and was associated with a high risk of rhegmatogenous RD, but did reduce the risk of severe VA loss in comparison with observation. This article contains additional online-only material available at http://www.ophsource.com/periodicals/ophtha.


Subject(s)
Choroid Hemorrhage/surgery , Choroidal Neovascularization/surgery , Macular Degeneration/surgery , Visual Acuity/physiology , Aged , Aged, 80 and over , Choroid Hemorrhage/physiopathology , Choroidal Neovascularization/etiology , Choroidal Neovascularization/physiopathology , Contrast Sensitivity/physiology , Female , Fluorescein Angiography , Follow-Up Studies , Humans , Intraoperative Complications , Macular Degeneration/complications , Macular Degeneration/physiopathology , Male , Middle Aged , Reading , Treatment Outcome
6.
Ophthalmology ; 111(11): 2007-14, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15522365

ABSTRACT

PURPOSE: To present and compare findings from health-related quality-of-life (HRQOL) interviews conducted with patients enrolled in the SST Group B Trial evaluating surgical removal of subfoveal choroidal neovascular lesions associated with age-related macular degeneration versus observation. DESIGN: Randomized clinical trial. PARTICIPANTS: Eligible patients had predominantly hemorrhagic subfoveal choroidal neovascular lesions (total lesion size of >3.5 disc areas, area of blood at least 50% of the lesion area, and at least 75% of blood posterior to the equator) and best-corrected visual acuity (VA) of 20/100 to <20/1600 but at least light perception in the study eye. Three hundred thirty-six patients enrolled after baseline quality-of-life interviews, 168 assigned to each of surgery or observation. METHODS: Clinical and HRQOL data were collected before randomization and at 6, 12, 24, 36, and 48 months after enrollment. Baseline clinical evidence was used to stratify patients as having unilateral or bilateral neovascularization at the time of randomization. The HRQOL interviews included the National Eye Institute Visual Function Questionnaire (NEI-VFQ), the 36-item Short Form Health Survey, and the Hospital Anxiety and Depression Scale. MAIN OUTCOMES MEASURE: Two-year change in NEI-VFQ. RESULTS: At 24 months after enrollment, overall NEI-VFQ scores had a median decrease of 1 point from baseline in the observation arm (95% confidence interval [CI]: -4 to 3 points) and no change in the surgery arm (95% CI: -3 to 3 points) (P = 0.70). Changes from baseline on NEI-VFQ subscales also were similar between treatment arms. Differences in scores by unilateral or bilateral involvement seen at baseline in each treatment arm persisted throughout follow-up for most outcomes. Planned analyses stratified by VA showed trends (P = 0.17) in favor of surgery at 24 months in the patients with baseline VA greater than 20/200 for the NEI-VFQ scale (3.5-point median increase from baseline in the surgery arm [95% CI: -4 to 7] vs. a 1-point median loss from baseline in the observation arm [95% CI: -6 to 4]). CONCLUSIONS: No difference was detected with respect to vision-targeted quality-of-life outcomes for patients randomized to surgery or observation in the SST Group B Trial. This article contains additional online-only material available at www.ophsource.com/periodicals/ophtha.


Subject(s)
Choroid Hemorrhage/psychology , Choroidal Neovascularization/psychology , Macular Degeneration/psychology , Quality of Life , Aged , Aged, 80 and over , Choroid Hemorrhage/etiology , Choroid Hemorrhage/surgery , Choroidal Neovascularization/etiology , Choroidal Neovascularization/surgery , Female , Follow-Up Studies , Health Status , Humans , Macular Degeneration/complications , Macular Degeneration/surgery , Male , Middle Aged , National Institutes of Health (U.S.) , Surveys and Questionnaires , United States , Visual Acuity
7.
Am J Ophthalmol ; 138(1): 91-108, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15234287

ABSTRACT

PURPOSE: To describe the effect of subfoveal choroidal neovascularization (CNV) from age-related macular degeneration (AMD) on health-related quality of life (HRQOL) of patients at enrollment in two randomized clinical trials; to examine the relation of visual acuity to HRQOL; to compare HRQOL scores between participants with unilateral and bilateral CNV independent of other characteristics. DESIGN: Randomized clinical trials. METHODS: Two Submacular Surgery Trials (SST) recruited patients with AMD and either new subfoveal CNV (Group N Trial) or predominantly hemorrhagic CNV (Group B Trial). Health-related quality of life interviews included the National Eye Institute Visual Function Questionnaire [NEI-VFQ], the SF-36 Health Survey, and the Hospital Anxiety and Depression Scale [HADS]. Linear correlation and regression analyses were used to relate baseline HRQOL scores to visual acuity and bilateral disease. RESULTS: Interview data were analyzed for 789 AMD patients: 454 patients in the Group N Trial and 335 patients in the Group B Trial. Participants reported poor vision-related functioning in many domains measured by the NEI-VFQ (mean overall scores of 65 for Group N and 63 for Group B). Visual acuity of the better eye was strongly associated with NEI-VFQ scores but not with SF-36 or HADS scores. After adjusting for visual acuity of the better eye and other factors, bilateral cases had NEI-VFQ overall scores six points lower than unilateral cases in Group N Trial and 10 points lower than unilateral cases in the Group B Trial. CONCLUSIONS: Subfoveal CNV profoundly affects vision-related quality of life. The effect is more pronounced with bilateral disease, even after controlling for visual acuity.


Subject(s)
Choroidal Neovascularization/psychology , Health Status , Macular Degeneration/psychology , Quality of Life/psychology , Visual Acuity/physiology , Aged , Aged, 80 and over , Choroidal Neovascularization/etiology , Female , Fluorescein Angiography , Humans , Macular Degeneration/complications , Male , Middle Aged , National Institutes of Health (U.S.) , Sickness Impact Profile , Surveys and Questionnaires , United States
8.
Am J Ophthalmol ; 137(2): 373-5, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14962442

ABSTRACT

PURPOSE: To report the responsiveness of the SF-36 Health Survey to changes in visual acuity among patients with subfoveal choroidal neovascularization participating in the Submacular Surgery Trials pilot study. DESIGN: Cohort study. METHODS: Correlation analyses were used to explore relationships at each time point, and linear regression was used to determine the relation between the 2-year changes in SF-36 scores and visual acuity. RESULTS: A weak, but statistically significant, association was found between the 2-year changes in both the Physical Component Summary score and the Physical Functioning subscale with changes in visual acuity of the better eye. No association was found between changes in visual acuity and the Mental Component Summary score or the Mental Health subscale. CONCLUSIONS: The SF-36 summary scales and the individual subscales were minimally responsive to 2-year changes in visual acuity in this subgroup of patients.


Subject(s)
Choroidal Neovascularization/physiopathology , Fovea Centralis/physiopathology , Health Surveys , Sickness Impact Profile , Visual Acuity/physiology , Aged , Choroidal Neovascularization/etiology , Clinical Trials as Topic , Female , Humans , Macular Degeneration/complications , Macular Degeneration/physiopathology , Male , Sensitivity and Specificity , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...